Dermata Therapeutics, Inc.

DRMAW Stock Healthcare Biotechnology
$0.00
-0.00 (-50.00%)
Price as of Aug 17, 2026 market close

Performance

1 Month
-94.8%
3 Months
-95.7%
YTD
-97.5%
1 Year
-96.9%
3 Year annualized
-72.4%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
201.4%
Largest decline max drawdown, since Sep 2021
-100.0%
Risk-adjusted return Sharpe ratio, 1-year
-0.61

Own DRMAW?

See how DRMAW contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.